There Are Few Good COVID Antivirals, but That Could Be Changing
Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort
Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.
Genomic sequencing efforts are limited in developing countries, but scientists are mobilizing to help
More than a year into the SARS-CoV-2 pandemic, some scientists say the possibility of a lab leak never got a fair look.
Vaccine makers are designing follow-up shots, based on new mutations, to keep the disease at bay
Companies are scrambling to obtain supplies for hundreds of millions of doses of a type of vaccine that has never been made at this scale before
Copyright © 2025 | WordPress Theme by MH Themes